Is Now the Time for Income Investors to Buy This Big Pharma Stock?
Much of that debt of gratitude for being able to return to normalcy is owed to the pharmaceutical behemoth Pfizer (NYSE: PFE). Let's dive into Pfizer's fundamentals and valuation to see if we can address this question. Since its founding in 1849, Pfizer has grown into a gargantuan business.